Joseph Ciaffoni - Net Worth and Insider Trading

Joseph Ciaffoni Net Worth

The estimated net worth of Joseph Ciaffoni is at least $10 Million dollars as of 2023-03-30. Joseph Ciaffoni is the President and CEO of Collegium Pharmaceutical Inc and owns about 400,087 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $10 Million. Details can be seen in Joseph Ciaffoni's Latest Holdings Summary section.

Transaction Summary of Joseph Ciaffoni

To

Joseph Ciaffoni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Ciaffoni owns 2 companies in total, including Collegium Pharmaceutical Inc (COLL) , and Endo International PLC (ENDPQ) .

Click here to see the complete history of Joseph Ciaffoni’s form 4 insider trades.

Insider Ownership Summary of Joseph Ciaffoni

Ticker Comapny Transaction Date Type of Owner
COLL Collegium Pharmaceutical Inc 2022-02-10 director & President and CEO
ENDPQ Endo International PLC 2016-08-15 President & U.S. Branded Pharma

Joseph Ciaffoni Latest Holdings Summary

Joseph Ciaffoni currently owns a total of 1 stock. Joseph Ciaffoni owns 400,087 shares of Collegium Pharmaceutical Inc (COLL) as of February 13, 2023, with a value of $10 Million.

Latest Holdings of Joseph Ciaffoni

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2023-02-13 400,087 24.00 9,602,088

Holding Weightings of Joseph Ciaffoni


Joseph Ciaffoni Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Ciaffoni has made a total of 12 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 11,250 shares on February 13, 2023, which brought Joseph Ciaffoni around $302,400.

Insider Trading History of Joseph Ciaffoni

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
COLL
Collegium Pharmaceutical Inc
2023-02-13
Sell
11,250.00
-2.73%
$26.88
$302,400.00
400,087.00
$24.00
-10.71%
2023-02-14
COLL
Collegium Pharmaceutical Inc
2022-12-27
Sell
2,461.00
-0.98%
$23.67
$58,251.90
248,750.00
$24.00
1.39%
2022-12-27
COLL
Collegium Pharmaceutical Inc
2022-12-21
Sell
17,842.00
-6.63%
$23.08
$411,793.00
251,211.00
$24.00
3.99%
2022-12-21
COLL
Collegium Pharmaceutical Inc
2022-12-02
Sell
131,053.00
-32.75%
$22.72
$2,977,520.00
269,053.00
$24.00
5.63%
2022-12-05
COLL
Collegium Pharmaceutical Inc
2022-11-18
Sell
1,989.00
-0.61%
$22.02
$43,797.80
323,453.00
$24.00
8.99%
2022-11-22
COLL
Collegium Pharmaceutical Inc
2021-03-01
Sell
64,768.00
-18.88%
$22.67
$1,468,290.00
278,307.00
$24.00
5.87%
-
COLL
Collegium Pharmaceutical Inc
2020-06-02
Sell
76,537.00
-28.42%
$21.45
$1,641,720.00
192,798.00
$24.00
11.89%
-
COLL
Collegium Pharmaceutical Inc
2019-11-07
Sell
64,821.00
-26.76%
$18.77
$1,216,690.00
177,455.00
$24.00
27.86%
-
COLL
Collegium Pharmaceutical Inc
2019-06-03
Sell
13,287.00
-6.87%
$11.56
$153,598.00
180,222.00
$24.00
107.61%
-
COLL
Collegium Pharmaceutical Inc
2018-06-01
Sell
79,683.00
-47.46%
$22.59
$1,800,040.00
88,201.00
$24.00
6.24%
-
Total 10
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Ciaffoni Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Ciaffoni Ownership Network

Ownership Network List of Joseph Ciaffoni

No Data

Ownership Network Relation of Joseph Ciaffoni


Joseph Ciaffoni Owned Company Details

What does Collegium Pharmaceutical Inc do?

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Who are the key executives at Collegium Pharmaceutical Inc?

Joseph Ciaffoni is the director & President and CEO of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP & Chief Financial Officer Tupper Colleen , and EVP and Chief Medical Officer Richard Malamut .

Collegium Pharmaceutical Inc (COLL) Insider Trades Summary

Over the past 18 months, Joseph Ciaffoni made 7 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 164,703. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 298,612 shares made by Michael Thomas Heffernan , a net sale of 60,700 shares made by Shirley R. Kuhlmann , and a net sale of 34,086 shares made by Scott Dreyer .

In summary, during the past 3 months, insiders sold 50,895 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 50,895 shares. During the past 18 months, 562,451 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 562,451 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Collegium Pharmaceutical Inc Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Joseph Ciaffoni Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Ciaffoni. You might contact Joseph Ciaffoni via mailing address: 100 Technology Center Drive, Stoughton Ma 02072.